Kinjal M. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kinjal M. Patel has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Ronak G. Desai
Adult Cardiothoracic Anesthesiology, Cooper University Healthcare, Cooper Medical School of Rowan University, Camden, NJ
12 shared publications- Sandeep Krishnan
Anesthesiology, Wayne State University School of Medicine, Detroit, USA
8 shared publications Sandeep Krishnan
Affiliation Department of Anesthesiology, Wayne State University School of Medicine, Pontiac, Michigan, United States of America
7 shared publications- Ronak Desai
Anesthesiology, Cooper University Hospital, Camden, USA
6 shared publications Keyur Trivedi
Affiliations Cooper Medical School of Rowan University, Camden, New Jersey, United States of America, Cooper University Hospital, Camden, New Jersey, United States of America, Department of Anesthesiology, Cooper University Hospital, Camden, New Jersey, United States of America
5 shared publicationsNoud van Helmond
Affiliations Cooper Medical School of Rowan University, Camden, New Jersey, United States of America, Cooper University Hospital, Camden, New Jersey, United States of America, Department of Anesthesiology, Cooper University Hospital, Camden, New Jersey, United States of America
5 shared publications
Latest Publications
- Open Access
- 12 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325954
The optimal warming strategy to reduce perioperative hypothermia: A prospective randomized non-blinded clinical trial
Background: To mitigate perioperative hypothermia, patients can be warmed preoperatively and intraoperatively with forced-air warming (FAW) and conductive warming (CW) methods. We examined the association of four combinations of pre- and intraoperative CW and FAW with the magnitude of intraoperative hypothermia. Methods: We conducted a prospective randomized trial at a tertiary healthcare center in the United States (trial registration number ISRCTN23065394). Patients were randomized to 4 arms based on the following pre/intraoperative warming combinations: (1) CW/CW, (2) FAW/FAW, (3) no active prewarming (NAPW)/CW, (4) NAPW/FAW. Body temperature was measured using an esophageal probe. The area under the temperature curve (AUC) below 36°C was calculated according to the trapezoidal rule and quantified intraoperative hypothermia. A mixed model was used to estimate differences in AUC between the 4 arms. Results: 182 patients were analyzed. Patients in the NAPW/FAW arm had the highest AUC values while those in the CW/CW arm had the lowest. AUC values [median (Q1, Q3] were as follows: CW/CW = 4.7 (0, 26.6); FAW/FAW = 8.0 (0, 30.8); NAPW/CW = 7.4 (0, 27.1); NAPW/FAW = 19.9 (5.0, 44.3). Mixed model results showed significant lower AUC values in CW/CW and NAPW/CW when compared to NAPW/FAW. The ratio of mean AUC [95% CI] between CW/CW vs NAPW/FAW was 0.49 [0.24, 0.98], 51% lower, and between NAPW/CW and NAPW/FAW, 0.46 [0.23, 0.91], 54% lower. When the AUC was normalized to the duration of surgery (AUC/case duration in°C, or “relative AUC”), significant lower relative AUC values were observed between FAW/FAW vs NAPW/FAW (48% lower, p = 0.0419) and NAPW/CW vs NAPW/FAW (48% lower, p = 0.0407). Conclusions: CW is more effective than FAW at reducing intraoperative hypothermia when FAW is used without prewarming. When patients are actively prewarmed, CW and FAW show no difference in their ability to maintain patient temperature.
- 12 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325954
Open AccessThe optimal warming strategy to reduce perioperative hypothermia: A prospective randomized non-blinded clinical trial
Background: To mitigate perioperative hypothermia, patients can be warmed preoperatively and intraoperatively with forced-air warming (FAW) and conductive warming (CW) methods. We examined the association of four combinations of pre- and intraoperative CW and FAW with the magnitude of intraoperative hypothermia. Methods: We conducted a prospective randomized trial at a tertiary healthcare center in the United States (trial registration number ISRCTN23065394). Patients were randomized to 4 arms based on the following pre/intraoperative warming combinations: (1) CW/CW, (2) FAW/FAW, (3) no active prewarming (NAPW)/CW, (4) NAPW/FAW. Body temperature was measured using an esophageal probe. The area under the temperature curve (AUC) below 36°C was calculated according to the trapezoidal rule and quantified intraoperative hypothermia. A mixed model was used to estimate differences in AUC between the 4 arms. Results: 182 patients were analyzed. Patients in the NAPW/FAW arm had the highest AUC values while those in the CW/CW arm had the lowest. AUC values [median (Q1, Q3] were as follows: CW/CW = 4.7 (0, 26.6); FAW/FAW = 8.0 (0, 30.8); NAPW/CW = 7.4 (0, 27.1); NAPW/FAW = 19.9 (5.0, 44.3). Mixed model results showed significant lower AUC values in CW/CW and NAPW/CW when compared to NAPW/FAW. The ratio of mean AUC [95% CI] between CW/CW vs NAPW/FAW was 0.49 [0.24, 0.98], 51% lower, and between NAPW/CW and NAPW/FAW, 0.46 [0.23, 0.91], 54% lower. When the AUC was normalized to the duration of surgery (AUC/case duration in°C, or “relative AUC”), significant lower relative AUC values were observed between FAW/FAW vs NAPW/FAW (48% lower, p = 0.0419) and NAPW/CW vs NAPW/FAW (48% lower, p = 0.0407). Conclusions: CW is more effective than FAW at reducing intraoperative hypothermia when FAW is used without prewarming. When patients are actively prewarmed, CW and FAW show no difference in their ability to maintain patient temperature.
- 1 December 2024
- Vol. 27 (10) , E1117-E1122
Pectoralis I and Serratus Anterior Plane Block Analgesia for Bilateral Mastectomy: A Case Series
Background: Poorly controlled acute breast surgery postoperative pain is associated with delayed recovery, increased morbidity, impaired quality of life, and prolonged opioid use during and after hospitalization. Recently, ultrasound-guided pectoralis nerve (PECS) I block and serratus anterior plane (SAP) block, together or individually, have emerged as a potential method to relieve pain, decrease opioid requirements, and improve patient outcomes. Objective: The aim of this study was to assess if the addition of a PECS I/SAP block in patients undergoing bilateral mastectomies provides more effective perioperative analgesia compared to standard analgesia. Study Design: Retrospective case series. Setting: Tertiary academic medical center. Methods: For patients undergoing breast cancer surgery, different approaches to analgesia by anesthesiologists at our institution provided an opportunity to compare patients who received a PECS I/SAP block to patients who received standard peri- and postoperative pain control from May 1, 2019 through November 30, 2020. Adult women who had bilateral mastectomy and reconstruction with tissue expanders for breast cancer were included. Bilateral PECS I/SAP blocks were performed with 60 mL 0.25% bupivacaine and 266 mg liposomal bupivacaine. The standard analgesia group had a balanced general anesthetic with volatile anesthetic, opioids (fentanyl or hydromorphone), and muscle relaxant. The postoperative analgesic regimen was similar in both groups. Pain scores (Numeric rating Scale) and opioid consumption (converted to oral morphine milligram equivalent [MME]) intraoperatively, and on postop day (POD) 0 up to POD 3 were collected. Length of stay data were collected as a secondary outcome. Results: Forty patients were included (n = 17 PECS I/SAP block; n = 23 standard analgesia). Baseline characteristics were similar between groups; most patients in the PECS I/SAP block (93%) and standard analgesia (96%) groups were discharged on POD 1 or 2. Intra-operative opioid requirements were lower in the PECS I/SAP block vs the standard analgesia group (median 56 MME, interquartile range [IQR] 44-62 vs median 65 MME, IQR 63-83, respectively, P = 0.002). Opioid requirements were similar in the block group compared to the standard analgesia group from POD 0 to POD 2. Pain scores from POD 0 to POD2, postanesthesia care unit length of stay, and hospital length of stay were also similar between the PECS I/SAP block and standard analgesia group. Limitations: The retrospective nature of this study and its reliance on medical records are limitations. Conclusion: The PECS I/SAP block may potentially reduce pain in patients having breast surgery for cancer by providing analgesia to the lateral and anterior chest wall. While this analysis showed a reduction in intraoperative opioid consumption, no significant postoperative benefit in either pain scores, opioid consumption, or length of stay was observed. This may be in part due to the PECS I/ SAP block not providing adequate analgesia to the medial portion of the breast.
- 1 December 2024
- Vol. 27 (10) , E1117-E1122
Pectoralis I and Serratus Anterior Plane Block Analgesia for Bilateral Mastectomy: A Case Series
Background: Poorly controlled acute breast surgery postoperative pain is associated with delayed recovery, increased morbidity, impaired quality of life, and prolonged opioid use during and after hospitalization. Recently, ultrasound-guided pectoralis nerve (PECS) I block and serratus anterior plane (SAP) block, together or individually, have emerged as a potential method to relieve pain, decrease opioid requirements, and improve patient outcomes. Objective: The aim of this study was to assess if the addition of a PECS I/SAP block in patients undergoing bilateral mastectomies provides more effective perioperative analgesia compared to standard analgesia. Study Design: Retrospective case series. Setting: Tertiary academic medical center. Methods: For patients undergoing breast cancer surgery, different approaches to analgesia by anesthesiologists at our institution provided an opportunity to compare patients who received a PECS I/SAP block to patients who received standard peri- and postoperative pain control from May 1, 2019 through November 30, 2020. Adult women who had bilateral mastectomy and reconstruction with tissue expanders for breast cancer were included. Bilateral PECS I/SAP blocks were performed with 60 mL 0.25% bupivacaine and 266 mg liposomal bupivacaine. The standard analgesia group had a balanced general anesthetic with volatile anesthetic, opioids (fentanyl or hydromorphone), and muscle relaxant. The postoperative analgesic regimen was similar in both groups. Pain scores (Numeric rating Scale) and opioid consumption (converted to oral morphine milligram equivalent [MME]) intraoperatively, and on postop day (POD) 0 up to POD 3 were collected. Length of stay data were collected as a secondary outcome. Results: Forty patients were included (n = 17 PECS I/SAP block; n = 23 standard analgesia). Baseline characteristics were similar between groups; most patients in the PECS I/SAP block (93%) and standard analgesia (96%) groups were discharged on POD 1 or 2. Intra-operative opioid requirements were lower in the PECS I/SAP block vs the standard analgesia group (median 56 MME, interquartile range [IQR] 44-62 vs median 65 MME, IQR 63-83, respectively, P = 0.002). Opioid requirements were similar in the block group compared to the standard analgesia group from POD 0 to POD 2. Pain scores from POD 0 to POD2, postanesthesia care unit length of stay, and hospital length of stay were also similar between the PECS I/SAP block and standard analgesia group. Limitations: The retrospective nature of this study and its reliance on medical records are limitations. Conclusion: The PECS I/SAP block may potentially reduce pain in patients having breast surgery for cancer by providing analgesia to the lateral and anterior chest wall. While this analysis showed a reduction in intraoperative opioid consumption, no significant postoperative benefit in either pain scores, opioid consumption, or length of stay was observed. This may be in part due to the PECS I/ SAP block not providing adequate analgesia to the medial portion of the breast.
- 15 December 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (3) , 604-607
Conduit Choice in Coronary Artery Bypass Grafting: Insights From an Expert Systematic Review Endorsed by the European Association for Cardio-Thoracic Surgery and the Society of Thoracic Surgeons
- 15 December 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (3) , 604-607
Conduit Choice in Coronary Artery Bypass Grafting: Insights From an Expert Systematic Review Endorsed by the European Association for Cardio-Thoracic Surgery and the Society of Thoracic Surgeons
- 17 September 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (1) , 12-15
Outcomes for Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation After 10-Year Analysis of the Extracorporeal Life Support Organization Registry—What Lessons Can Be Learned?
- 17 September 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (1) , 12-15
Outcomes for Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation After 10-Year Analysis of the Extracorporeal Life Support Organization Registry—What Lessons Can Be Learned?
- Open Access
- 1 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e30964
Superficial Parasternal Intercostal Plane Blocks (SPIB) With Buprenorphine, Magnesium, and Bupivacaine for Management of Pain in Coronary Artery Bypass Grafting
Management of post-operative pain after cardiac surgery continues to be a challenge; inadequate management of pain can lead to increased morbidity, impaired physical function with potential delay in recovery, increased perioperative and chronic opioid consumption, increased cost of care, and a decreased quality of life. This study aimed to evaluate the effect of adding buprenorphine and magnesium to bupivacaine for superficial parasternal intercostal plane blocks (SPIB) on pain and opioid consumption in the first 24 hours after coronary artery bypass grafting (CABG). Patients undergoing CABG were divided into the following four groups: saline SPIB, SPIB with bupivacaine (BPVC), SPIB with bupivacaine and buprenorphine (BPVC+BPRN), and SPIB with bupivacaine, buprenorphine, and magnesium (BPVC+BPRN+MG). The primary outcomes were pain scores and opioid consumption after SPIB; the secondary outcomes were post-operative nausea and vomiting, time to extubation, and length of stay (LOS) in the intensive care unit and hospital. One hundred thirty-four eligible patients undergoing CABG were randomized to either the saline (n=27), BPVC (n=20), BPVC+BPRN (n=24), or BPVC+BPRN+MG (n=29) group. All of the intervention groups combined (BPVC, BPVC+BPRN, and BPVC+BPRN+MG) had decreased pain scores and decreased opioid consumption when compared to the saline group; although not statistically significant, visual analog scale (VAS) scores trended downward at most time points with BPVC versus saline, BPVC+BPRN versus BPVC, and BPVC+BPRN+MG versus BPVC+BPRN. There was no difference among the study groups in the incidence of post-operative nausea and/or vomiting (PONV), time to extubation, hospital LOS, and ICU LOS. In this prospective, double-blind, placebo-controlled trial, we found that SPIB with local anesthetic is effective at reducing VAS scores and opioid consumption after CABG. Further study is needed to determine whether the addition of adjuvants can further improve pain control and opioid consumption.
- 1 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e30964
Open AccessSuperficial Parasternal Intercostal Plane Blocks (SPIB) With Buprenorphine, Magnesium, and Bupivacaine for Management of Pain in Coronary Artery Bypass Grafting
Management of post-operative pain after cardiac surgery continues to be a challenge; inadequate management of pain can lead to increased morbidity, impaired physical function with potential delay in recovery, increased perioperative and chronic opioid consumption, increased cost of care, and a decreased quality of life. This study aimed to evaluate the effect of adding buprenorphine and magnesium to bupivacaine for superficial parasternal intercostal plane blocks (SPIB) on pain and opioid consumption in the first 24 hours after coronary artery bypass grafting (CABG). Patients undergoing CABG were divided into the following four groups: saline SPIB, SPIB with bupivacaine (BPVC), SPIB with bupivacaine and buprenorphine (BPVC+BPRN), and SPIB with bupivacaine, buprenorphine, and magnesium (BPVC+BPRN+MG). The primary outcomes were pain scores and opioid consumption after SPIB; the secondary outcomes were post-operative nausea and vomiting, time to extubation, and length of stay (LOS) in the intensive care unit and hospital. One hundred thirty-four eligible patients undergoing CABG were randomized to either the saline (n=27), BPVC (n=20), BPVC+BPRN (n=24), or BPVC+BPRN+MG (n=29) group. All of the intervention groups combined (BPVC, BPVC+BPRN, and BPVC+BPRN+MG) had decreased pain scores and decreased opioid consumption when compared to the saline group; although not statistically significant, visual analog scale (VAS) scores trended downward at most time points with BPVC versus saline, BPVC+BPRN versus BPVC, and BPVC+BPRN+MG versus BPVC+BPRN. There was no difference among the study groups in the incidence of post-operative nausea and/or vomiting (PONV), time to extubation, hospital LOS, and ICU LOS. In this prospective, double-blind, placebo-controlled trial, we found that SPIB with local anesthetic is effective at reducing VAS scores and opioid consumption after CABG. Further study is needed to determine whether the addition of adjuvants can further improve pain control and opioid consumption.
- 13 October 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (1) , 149-157
Echocardiographic Diagnosis and Management of Unexpected Pulmonary Vein Stenosis After Aortic Valve Replacement
- 13 October 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 37 (1) , 149-157
Echocardiographic Diagnosis and Management of Unexpected Pulmonary Vein Stenosis After Aortic Valve Replacement
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 2707-2718
Blunt Trauma to the Heart: A Review of Pathophysiology and Current Management
- 1 August 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (8) , 2707-2718
Blunt Trauma to the Heart: A Review of Pathophysiology and Current Management
- Open Access
- 22 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26204
Postoperative Cognitive Dysfunction in the Elderly: A Role for Modafinil
Introductionː Postoperative cognitive dysfunction has long-term consequences of increased mortality, loss of autonomy, and prolonged hospitalization. We sought to determine whether exposing patients to modafinil may attenuate or prevent this devastating syndrome from affecting the elderly postoperatively. Methodsː Adults aged 65 and older and American Society of Anesthesiologists (ASA) I-III physical status scheduled for elective noncardiac/non-neurosurgical surgery were included. Subjects were tested with the Trail Making Test (TMT) and Rey Auditory Visual Learning Test (RAVLT) preoperatively as well as in the immediate postoperative period, at 1 week, and at 3 months. After baseline testing, patients were randomized into three groups: 0) placebo pre and post-procedure; 1) modafinil only pre-procedure and placebo post-procedure; and 2) modafinil pre and post-procedure. A nonsurgical control group was also utilized. Resultsː Seventy-six subjects completed the trial 3 months post-surgery. The baseline RAVLT obtained was analyzed with 2-way ANOVA with repeated measures and showed improvement in learning in all groups (p = 0.03). At 1-week post-surgery, Group 0 subjects demonstrated no learning improvement in the RAVLT. However, there was a significant improvement in learning in both groups that received modafinil (p<0.01), and in the nonsurgical controls (p<0.01). This learning benefit normalized at 3 months. Conclusionː In this prospective, double-blind, placebo-controlled trial, we found that patients who received modafinil showed improvement in the RAVLT at 1 week. However, this learning benefit normalized at 3 months. Further study should examine dose effect, timing, and route of administration to determine if the effect can be enhanced and if in fact, wakefulness is improved post-surgically.
- 22 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26204
Open AccessPostoperative Cognitive Dysfunction in the Elderly: A Role for Modafinil
Introductionː Postoperative cognitive dysfunction has long-term consequences of increased mortality, loss of autonomy, and prolonged hospitalization. We sought to determine whether exposing patients to modafinil may attenuate or prevent this devastating syndrome from affecting the elderly postoperatively. Methodsː Adults aged 65 and older and American Society of Anesthesiologists (ASA) I-III physical status scheduled for elective noncardiac/non-neurosurgical surgery were included. Subjects were tested with the Trail Making Test (TMT) and Rey Auditory Visual Learning Test (RAVLT) preoperatively as well as in the immediate postoperative period, at 1 week, and at 3 months. After baseline testing, patients were randomized into three groups: 0) placebo pre and post-procedure; 1) modafinil only pre-procedure and placebo post-procedure; and 2) modafinil pre and post-procedure. A nonsurgical control group was also utilized. Resultsː Seventy-six subjects completed the trial 3 months post-surgery. The baseline RAVLT obtained was analyzed with 2-way ANOVA with repeated measures and showed improvement in learning in all groups (p = 0.03). At 1-week post-surgery, Group 0 subjects demonstrated no learning improvement in the RAVLT. However, there was a significant improvement in learning in both groups that received modafinil (p<0.01), and in the nonsurgical controls (p<0.01). This learning benefit normalized at 3 months. Conclusionː In this prospective, double-blind, placebo-controlled trial, we found that patients who received modafinil showed improvement in the RAVLT at 1 week. However, this learning benefit normalized at 3 months. Further study should examine dose effect, timing, and route of administration to determine if the effect can be enhanced and if in fact, wakefulness is improved post-surgically.
- 19 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (10) , 3715-3718
The AVATAR Trial for Severe Asymptomatic Aortic Stenosis: Wait or Operate?
- 19 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (10) , 3715-3718
The AVATAR Trial for Severe Asymptomatic Aortic Stenosis: Wait or Operate?